Potential inflammatory targets in the integrative health care of patients with sickle cell disease

被引:0
|
作者
Khan, Shahida A. [1 ,2 ]
Halawani, Saeed H. [3 ]
Al Zughaibi, Torki [1 ,2 ]
Khan, Sarah A. [1 ]
机构
[1] King Abdulaziz Univ, King Fahd Med Res Ctr, Jeddah 21589, Saudi Arabia
[2] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Lab Sci, Jeddah 22252, Saudi Arabia
[3] Umm Al Qura Univ, Fac Med, Dept Hematol & Immunol, Mecca 21955, Saudi Arabia
关键词
inflammation; marker; sickle cell disease; C-REACTIVE PROTEIN; VASOOCCLUSIVE CRISIS; HOMOCYSTEINE LEVEL; CHILDREN; ADOLESCENTS;
D O I
10.3892/etm.2023.12184
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Inflammation plays an integral role in the complications of sickle cell disease (SCD), which can lead to vaso-occlusive crisis and extreme pain. SCD is accompanied by numerous complications, including cardiovascular disease, cognitive decline and endothelial dysfunction, contributing to mortality. As disease severity increases with age, the present study aimed to assess if age is also correlated with a definite pattern of progression of the two inflammatory markers, high-sensitivity C-reactive protein (hsCRP) and total homocysteine (tHCY). The findings of the present study could lead to an improved understanding of the threshold levels of these inflammatory markers and timely interventions to delay complications. In an observational study, levels of hsCRP and tHCY were analyzed in 70 patients (35 male and 35 female patients) with SCD aged between 5 and 16 years. hsCRP levels were in the high-risk range in 64.29% (n=45) of all male and female patients. A sex-wise distribution showed that, of the 35 male patients, 74.28% (n=26) were in the high-risk range, and of the 35 female patients, 54.28% (n=19) were in the high-risk range. An age-wise distribution showed that of the 41 patients in the 5-10-years age group, 70.73% (n=29), were in the high-risk range. In comparison, of the 29 patients in the 11-16-years age group, 55.17% (n=16) were in the high-risk range. tHCY levels were observed to be in the normal range in 98.57% (n=69) of all children, as compared with 1.43% (n=1) in the high-risk range. Furthermore, a sex-wise distribution showed that female patients in the high-risk group of hsCRP had higher concentrations of tHCY as compared with the male patients in that risk group. An age-wise distribution of hsCRP concentration also showed that the risk of CVD in patients in the 11-16-years age group was higher with increased concentrations of tHCY. A weak negative correlation was observed between age and hsCRP concentrations (r-value=-0.280; P=0.026) and a weak positive correlation was detected between tHCY and age (r-value=0.259; P=0.036). In conclusion, the results of the present study indicated that higher levels of hsCRP could be a useful marker in children with SCD, and levels of tHCY may be an adjunct marker as the disease progresses with age.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Predictors of osteoclast activity in patients with sickle cell disease
    Nouraie, Mehdi
    Cheng, Kevin
    Niu, Xiaomei
    Moore-King, Evadne
    Fadojutimi-Akinsi, Margaret F.
    Minniti, Caterina P.
    Sable, Craig
    Rana, Sohail
    Dham, Niti
    Campbell, Andrew
    Ensing, Gregory
    Kato, Gregory J.
    Gladwin, Mark T.
    Castro, Oswaldo L.
    Gordeuk, Victor R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2011, 96 (08): : 1092 - 1098
  • [32] Health literacy in adolescents with sickle cell disease: The influence of caregiver health literacy
    Caldwell, Elizabeth P.
    JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING, 2020, 25 (02)
  • [33] Is the treatment of inflammatory arthritis different in sickle cell disease?
    Kimyon, Gezmis
    Ilhan, Gul
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (05) : 1721 - 1728
  • [34] Inflammatory Mediators of Endothelial Injury in Sickle Cell Disease
    Hoppe, Carolyn C.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (02) : 265 - +
  • [35] Anti-inflammatory cytokines in sickle cell disease
    Alagbe, Adekunle E.
    Domingos, Igor F.
    Adekile, Adekunle D.
    Blotta, Maria H. S. L.
    Santos, Magnun N. N.
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (03) : 2433 - 2442
  • [36] A novel inflammatory role for platelets in sickle cell disease
    Davila, Jennifer
    Manwani, Deepa
    Vasovic, Ljiljana
    Avanzi, Mauro
    Uehlinger, Joan
    Ireland, Karen
    Mitchell, W. Beau
    PLATELETS, 2015, 26 (08) : 726 - 729
  • [37] Potential Role for Statins in Sickle Cell Disease
    Adam, Soheir S.
    Hoppe, Carolyn
    PEDIATRIC BLOOD & CANCER, 2013, 60 (04) : 550 - 557
  • [38] Primary Care Providers' Comfort Levels in Caring for Patients with Sickle Cell Disease
    Whiteman, Lauren N.
    Haywood, Carlton, Jr.
    Lanzkron, Sophie
    Strouse, John J.
    Feldman, Leonard
    Stewart, Rosalyn W.
    SOUTHERN MEDICAL JOURNAL, 2015, 108 (09) : 531 - 536
  • [39] A Case-Based Approach to Transition of Care for Patients With Sickle Cell Disease
    Noronha, Suzie A.
    Pulcino, Tiffany L.
    Akwaa, Frank
    SOUTHERN MEDICAL JOURNAL, 2016, 109 (09) : 531 - 534
  • [40] Physical Therapy in Pediatric and Young Adult Patients With Sickle Cell Disease: Assessing Potential Benefits and Barriers
    Callaway, Daniel
    Chawla, Anjulika
    Sprinz, Philippa
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (08) : 463 - 466